Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,520 | -51,511 | -36,489 | -22,901 | -10,910 |
| Depreciation Amortization | -650 | -842 | -276 | -4 | 40 |
| Accounts payable and accrued liabilities | 2,121 | 1,368 | 3,117 | 875 | 1,587 |
| Other Working Capital | 3,362 | 7,755 | 8,761 | 6,120 | 4,185 |
| Other Operating Activity | 263 | 4,108 | 630 | 1,373 | -563 |
| Operating Cash Flow | $-11,424 | $-39,122 | $-24,257 | $-14,537 | $-5,661 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,391 | 7,121 | -7,369 | -12,047 | -20,371 |
| PPE Investments | -16 | -195 | -191 | -158 | -28 |
| Investing Cash Flow | $15,375 | $6,926 | $-7,560 | $-12,205 | $-20,399 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 223 | 767 | 174 | 2 | 0 |
| Other Financing Activity | 0 | -371 | -135 | 0 | 0 |
| Financing Cash Flow | $223 | $396 | $39 | $2 | $0 |
| Beginning Cash Position | 22,397 | 54,197 | 54,197 | 54,197 | 54,197 |
| End Cash Position | 26,571 | 22,397 | 22,419 | 27,457 | 28,137 |
| Net Cash Flow | $4,174 | $-31,800 | $-31,778 | $-26,740 | $-26,060 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,424 | -39,122 | -24,257 | -14,537 | -5,661 |
| Capital Expenditure | -16 | -195 | -191 | -158 | -28 |
| Free Cash Flow | -11,440 | -39,317 | -24,448 | -14,695 | -5,689 |